Cargando…

A case of chronic myelogenous leukemia with the T315I mutation who progressed to myeloid blast phase and was successfully treated with asciminib

Patients with chronic myelogenous leukemia (CML) harboring the T315I mutation who progress to blast phase CML while on ponatinib may be successfully treated with asciminib monotherapy following induction therapy with cytotoxic chemotherapy.

Detalles Bibliográficos
Autores principales: Tomassetti, Sarah, Lee, Jennifer, Qing, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637250/
https://www.ncbi.nlm.nih.gov/pubmed/36381034
http://dx.doi.org/10.1002/ccr3.6478
_version_ 1784825143118266368
author Tomassetti, Sarah
Lee, Jennifer
Qing, Xin
author_facet Tomassetti, Sarah
Lee, Jennifer
Qing, Xin
author_sort Tomassetti, Sarah
collection PubMed
description Patients with chronic myelogenous leukemia (CML) harboring the T315I mutation who progress to blast phase CML while on ponatinib may be successfully treated with asciminib monotherapy following induction therapy with cytotoxic chemotherapy.
format Online
Article
Text
id pubmed-9637250
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-96372502022-11-14 A case of chronic myelogenous leukemia with the T315I mutation who progressed to myeloid blast phase and was successfully treated with asciminib Tomassetti, Sarah Lee, Jennifer Qing, Xin Clin Case Rep Case Report Patients with chronic myelogenous leukemia (CML) harboring the T315I mutation who progress to blast phase CML while on ponatinib may be successfully treated with asciminib monotherapy following induction therapy with cytotoxic chemotherapy. John Wiley and Sons Inc. 2022-11-06 /pmc/articles/PMC9637250/ /pubmed/36381034 http://dx.doi.org/10.1002/ccr3.6478 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Tomassetti, Sarah
Lee, Jennifer
Qing, Xin
A case of chronic myelogenous leukemia with the T315I mutation who progressed to myeloid blast phase and was successfully treated with asciminib
title A case of chronic myelogenous leukemia with the T315I mutation who progressed to myeloid blast phase and was successfully treated with asciminib
title_full A case of chronic myelogenous leukemia with the T315I mutation who progressed to myeloid blast phase and was successfully treated with asciminib
title_fullStr A case of chronic myelogenous leukemia with the T315I mutation who progressed to myeloid blast phase and was successfully treated with asciminib
title_full_unstemmed A case of chronic myelogenous leukemia with the T315I mutation who progressed to myeloid blast phase and was successfully treated with asciminib
title_short A case of chronic myelogenous leukemia with the T315I mutation who progressed to myeloid blast phase and was successfully treated with asciminib
title_sort case of chronic myelogenous leukemia with the t315i mutation who progressed to myeloid blast phase and was successfully treated with asciminib
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637250/
https://www.ncbi.nlm.nih.gov/pubmed/36381034
http://dx.doi.org/10.1002/ccr3.6478
work_keys_str_mv AT tomassettisarah acaseofchronicmyelogenousleukemiawiththet315imutationwhoprogressedtomyeloidblastphaseandwassuccessfullytreatedwithasciminib
AT leejennifer acaseofchronicmyelogenousleukemiawiththet315imutationwhoprogressedtomyeloidblastphaseandwassuccessfullytreatedwithasciminib
AT qingxin acaseofchronicmyelogenousleukemiawiththet315imutationwhoprogressedtomyeloidblastphaseandwassuccessfullytreatedwithasciminib
AT tomassettisarah caseofchronicmyelogenousleukemiawiththet315imutationwhoprogressedtomyeloidblastphaseandwassuccessfullytreatedwithasciminib
AT leejennifer caseofchronicmyelogenousleukemiawiththet315imutationwhoprogressedtomyeloidblastphaseandwassuccessfullytreatedwithasciminib
AT qingxin caseofchronicmyelogenousleukemiawiththet315imutationwhoprogressedtomyeloidblastphaseandwassuccessfullytreatedwithasciminib